Cargando…
Exploring macrophage cell therapy on Diabetic Kidney Disease
Alternatively activated macrophages (M2) have regenerative properties and shown promise as cell therapy in chronic kidney disease. However, M2 plasticity is one of the major hurdles to overcome. Our previous studies showed that genetically modified macrophages stabilized by neutrophil gelatinase‐ass...
Autores principales: | Guiteras, Roser, Sola, Anna, Flaquer, Maria, Manonelles, Anna, Hotter, Georgina, Cruzado, Josep M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349346/ https://www.ncbi.nlm.nih.gov/pubmed/30407737 http://dx.doi.org/10.1111/jcmm.13983 |
Ejemplares similares
-
Macrophage in chronic kidney disease
por: Guiteras, Roser, et al.
Publicado: (2016) -
siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice
por: Narváez, Alonso, et al.
Publicado: (2019) -
The influenza virus NS1A binding protein gene modulates macrophages response to cytokines and phagocytic potential in inflammation
por: Hotter, Georgina, et al.
Publicado: (2020) -
The Presence of Urinary Renal Progenitor Cells in Stable Kidney Transplant Recipients Anticipates Allograft Deterioration
por: Manonelles, Anna, et al.
Publicado: (2018) -
Chronic Kidney Allograft Disease: New Concepts and Opportunities
por: Codina, Sergi, et al.
Publicado: (2021)